The company placed 546 da Vinci systems, including 315 da Vinci 5 units, and 56 Ion systems, bringing its total da Vinci installed base to 12,094. For fiscal year 2026, it forecasts da Vinci procedure growth between 14% and 15% and adjusted gross margins from 68.7% to 69.3%. CEO Dave Rosa noted that customers performed an average of over 10,000 procedures per day across its platforms during the quarter.
